Regulatory Science and Policy Events
Receive updates about upcoming Regulatory and Science Policy Workshops, including information about workshop registration. You can also stay up-to-date on policy issues affecting cancer research by reading and subscribing to our Cancer Policy Monitor.
upcoming event
Optimizing Dosages for Oncology Drug Products (December 2023) **Details coming soon!
RECENT events
FDA-AACR-ASA Workshop: Overall Survival in Oncology Clinical Trials (July 18, 2023)
Regulatory Science and Policy Track at the AACR Annual Meeting 2023 (April 14-19, 2023)
Past Events
- Regulatory Science and Policy Track at the AACR Annual Meeting 2022 (April 8-13, 2022)
- Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (May 17-21, 2021)
- Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (June 22-24, 2020)
- NIH-AACR Cancer, Autoimmunity, and Immunology Conference 2020 (March 23-24, 2020)
- FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials (February 28, 2020)
- FDA-AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials (February 13, 2020)
- FDA-AACR Real-world Evidence Workshop (July 19, 2019)
- NIH-AACR Cancer, Autoimmunity, and Immunology Conference (April 15-16, 2019)
- (March 29-April 3, 2019)
- FDA-AACR Non-clinical Models for Safety Assessment of Immuno-oncology Products Workshop (September 6, 2018)
- FDA-AACR-SGO Drug Development for Gynecological Malignancies Workshop (June 14, 2018)
- Regulatory Science and Policy Track at the AACR Annual Meeting 2018 (April 14-18, 2018)
- FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop (February 22-23, 2018)
- FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part II (October 10, 2017)
- FDA-AACR Oncology Dose-finding Workshop Part III (July 20, 2017)
- Regulatory Science and Policy Track at the AACR Annual Meeting 2017 (April 1-4, 2017)
- FDA-AACR Immuno-oncology Drug Development Workshop (October 13-14, 2016)
- FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part I
- (July 19, 2016)
- FDA-AACR Oncology Dose-finding Workshop Part II (June 13, 2016)
- Regulatory Science and Policy Track at AACR Annual Meeting 2016 (April 16-20, 2016)
- Ovarian Cancer Endpoints Workshop (September 3, 2015)
- Dose-finding of Small Molecule Oncology Drugs Workshop Part I (May 18-19, 2015)
- Regulatory Science and Policy Track at AACR Annual Meeting 2015 (April 18-22, 2015)
- Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies (March 24, 2015)
- Regulatory Science and Policy Track at AACR Annual Meeting 2014 (April 5-9, 2014)
- FDA-AACR-ASCO-BCRF Innovations in Breast Cancer Drug Development- Next Generation Oncology Trials Workshop (October 21, 2014)
- AACR-AdvaMedDx Cancer Diagnostics Symposium: Transforming Cancer Care through Diagnostics and Personalized Medicine (October 29, 2013)
- AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Combining Immunotherapies, Immune Modulators, and Targeted Therapies: Regulatory Opportunities Challenges (October 23, 2013)
- Regulatory Science and Policy Track at AACR Annual Meeting 2013 (April 6-10, 2013)
- Regulatory Science and Policy Track at AACR Annual Meeting 2012 (March 31- April 4, 2012)